Dr Reddy launches world’s 1st immuno-onco drug for nasopharyngeal cancer in India | India News – Times of India
HYDERABAD: Pharma major Dr Reddy’s Laboratories Ltd on Thursday said it has rolled out Toripalimab, the world’s first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma, which is a rare form of head and neck cancer, in the Indian market.With this, India becomes the third country in the world after China and…